Literature DB >> 9756907

Characterization of distinct human endometrial carcinoma cell lines deficient in mismatch repair that originated from a single tumor.

W E Glaab1, J I Risinger, A Umar, T A Kunkel, J C Barrett, K R Tindall.   

Abstract

The role of specific mismatch repair (MMR) gene products was examined by observing several phenotypic end points in two MMR-deficient human endometrial carcinoma cell lines that were originally isolated from the same tumor. The first cell line, HEC-1-A, contains a nonsense mutation in the hPMS2 gene, which results in premature termination and a truncated hPMS2 protein. In addition, HEC-1-A cells carry a splice mutation in the hMSH6 gene and lack wild-type hMSH6 protein. The second cell line, HEC-1-B, possesses the same defective hMSH6 locus. However, HEC-1-B cells are heterozygous at the hPMS2 locus; that is, along with carrying the same nonsense mutation in hPMS2 as in HEC-1-A, HEC-1-B cells also contain a wild-type hPMS2 gene. Initial recognition of mismatches in DNA requires either the hMSH2/hMSH6 or hMSH2/hMSH3 heterodimer, with hPMS2 functioning downstream of damage recognition. Therefore, cells defective in hPMS2 should completely lack MMR (HEC-1-A), whereas cells mutant in hMSH6 only (HEC-1-B) can potentially repair damage via the hMSH2/hMSH3 heterodimer. The data presented here in HEC-1-B cells illustrate (i) the reduction of instability at microsatellite sequences, (ii) a significant decrease in frameshift mutation rate at HPRT, and (iii) the in vitro repair of looped substrates, relative to HEC-1-A cells, illustrating the repair of frameshift intermediates by hMSH2/hMSH3 heterodimer. Furthermore, the role of hMSH2/hMSH3 heterodimer in the repair of base:base mismatches is supported by observing the reduction in base substitution mutation rate at HPRT in HEC-1-B cells (hMSH6-defective but possessing wild-type hPMS2), as compared with HEC-1-A (hMSH6/hPMS2-defective) cells. These data support a critical role for hPMS2 in human MMR, while further defining the role of the hMSH2/hMSH3 heterodimer in maintaining genomic stability in the absence of a wild-type hMSH2/hMSH6 heterodimer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9756907     DOI: 10.1074/jbc.273.41.26662

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Multiple mutations and frameshifts are the hallmark of defective hPMS2 in pZ189-transfected human tumor cells.

Authors:  S Ceccotti; C Ciotta; G Fronza; E Dogliotti; M Bignami
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

2.  Quantifying the contributions of base selectivity, proofreading and mismatch repair to nuclear DNA replication in Saccharomyces cerevisiae.

Authors:  Jordan A St Charles; Sascha E Liberti; Jessica S Williams; Scott A Lujan; Thomas A Kunkel
Journal:  DNA Repair (Amst)       Date:  2015-04-25

3.  Mononucleotide microsatellite instability and germline MSH6 mutation analysis in early onset colorectal cancer.

Authors:  L Verma; M F Kane; C Brassett; J Schmeits; D G Evans; R D Kolodner; E R Maher
Journal:  J Med Genet       Date:  1999-09       Impact factor: 6.318

Review 4.  Eukaryotic Mismatch Repair in Relation to DNA Replication.

Authors:  Thomas A Kunkel; Dorothy A Erie
Journal:  Annu Rev Genet       Date:  2015       Impact factor: 16.830

5.  Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome.

Authors:  Michel De Vos; Bruce E Hayward; Susan Picton; Eamonn Sheridan; David T Bonthron
Journal:  Am J Hum Genet       Date:  2004-04-07       Impact factor: 11.025

6.  TGFbeta signaling supports survival and metastasis of endometrial cancer cells.

Authors:  Xiufen Lei; Long Wang; Junhua Yang; Lu-Zhe Sun
Journal:  Cancer Manag Res       Date:  2009-04       Impact factor: 3.989

7.  The oxidized deoxynucleoside triphosphate pool is a significant contributor to genetic instability in mismatch repair-deficient cells.

Authors:  Maria Teresa Russo; Monica Francesca Blasi; Federica Chiera; Paola Fortini; Paolo Degan; Peter Macpherson; Masato Furuichi; Yusaku Nakabeppu; Peter Karran; Gabriele Aquilina; Margherita Bignami
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

8.  Human mismatch repair protein hMutLα is required to repair short slipped-DNAs of trinucleotide repeats.

Authors:  Gagan B Panigrahi; Meghan M Slean; Jodie P Simard; Christopher E Pearson
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

Review 9.  Modeling Endometrial Cancer: Past, Present, and Future.

Authors:  Tom Van Nyen; Cristian P Moiola; Eva Colas; Daniela Annibali; Frédéric Amant
Journal:  Int J Mol Sci       Date:  2018-08-09       Impact factor: 5.923

10.  Biological Activity of fac-[Re(CO)3(phen)(aspirin)], fac-[Re(CO)3(phen)(indomethacin)] and Their Original Counterparts against Ishikawa and HEC-1A Endometrial Cancer Cells.

Authors:  Olga Kuźmycz; Aleksandra Kowalczyk; Paweł Stączek
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.